International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards

Home > Other > International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards > Page 984
International GAAP® 2019: Generally Accepted Accounting Practice under International Financial Reporting Standards Page 984

by International GAAP 2019 (pdf)


  ordinary shares of investees, Ch. 33, 6.4.7

  treasury shares, Ch. 43, 9

  partly paid shares, Ch. 33, 6.4.4

  objective, Ch. 43, 2.1

  presentation, Ch. 33, 7.1

  options over puttable instruments classified as equity, Ch. 30,

  purchased options and warrants, Ch. 33, 6.4.3

  2.2.4.J

  restatement, Ch. 33, 7.2

  scope, Ch. 43, 2.2

  scope, Ch. 33, 2.2

  transactions in financial assets outside the scope of, Ch. 30,

  share based payments, Ch. 33, 6.4.5

  2.2.3.F

  IAS 34– Interim Financial Reporting, Ch. 37, 1–11; Ch. 50, 2.3

  transactions in the scope of (compared with IFRS 2), Ch. 30,

  components, form and content, Ch. 37, 3

  2.2.3.E

  complete set of interim financial statements, Ch. 37, 3.1

  IAS 33– Earnings per Share, Ch. 33, 1–8. See also Diluted EPS

  condensed interim financial statements, Ch. 37, 3.2

  basic EPS, Ch. 33, 3

  management commentary, Ch. 37, 3.4

  earnings, Ch. 33, 3.1

  requirements for both complete and condensed interim

  number of shares, Ch. 33, 3.2

  financial information, Ch. 37, 3.3

  changes in outstanding ordinary shares, Ch. 33, 4

  definitions, Ch. 37, 1.1

  adjustments to EPS in historical summaries, Ch. 33, 4.7

  disclosure in annual financial statements, Ch. 37, 7

  changes in ordinary shares without corresponding changes

  disclosures in condensed financial statements, Ch. 37, 4

  in resources, Ch. 33, 4.3

  disclosure of compliance with IFRS, Ch. 37, 4.6

  B share schemes, Ch. 33, 4.3.4

  examples of disclosures, Ch. 37, 4.3

  capitalisation, bonus issues and share splits, Ch. 33,

  accounting policies and methods of computation,

  4.3.1.A

  Ch. 37, 4.3.13

  put warrants priced above market value, Ch. 33, 4.3.5

  acquisition and disposal of property, plant and

  rights issue, Ch. 33, 4.3.3

  equipment, Ch. 37, 4.3.4

  share consolidation with a special dividend, Ch. 33,

  amounts that are unusual because of their nature, size

  4.3.2

  or incidence, Ch. 37, 4.3.15

  share consolidations, Ch. 33, 4.3.1.C

  capital commitments, Ch. 37, 4.3.5

  stock dividends, Ch. 33, 4.3.1.B

  changes in circumstances affecting fair values, Ch. 37,

  issue to acquire another business, Ch. 33, 4.6

  4.3.7

  acquisitions, Ch. 33, 4.6.1

  changes in classification of financial assets arising from

  establishment of a new parent undertaking, Ch. 33,

  changes in use, Ch. 37, 4.3.11

  4.6.3

  changes in estimates, Ch. 37, 4.3.16

  reverse acquisitions, Ch. 33, 4.6.2

  changes in the composition of the entity, Ch. 37,

  options exercised during the year, Ch. 33, 4.4

  4.3.20

  post balance sheet changes in capital, Ch. 33, 4.5

  contingent liabilities, Ch. 37, 4.3.12

  purchase and redemption of own shares, Ch. 33, 4.2

  default/breach of loan covenants not remedied before

  weighted average number of shares, Ch. 33, 4.1

  the end of interim period, Ch. 37, 4.3.8

  contingently issuable potential ordinary shares, Ch. 33, 6.4.8

  dividends paid for each class of share, Ch. 37, 4.3.18

  contingently issuable shares, Ch. 33, 6.4.6

  events after the interim reporting date, Ch. 37, 4.3.19

  earnings-based contingencies, Ch. 33, 6.4.6.A

  impairment, Ch. 37, 4.3.2

  share-price-based contingencies, Ch. 33, 6.4.6.B

  inventory write-down and reversals, Ch. 37, 4.3.1

  convertible instruments, Ch. 33, 6.4.1

  issues, repurchases and repayments of debt and equity

  convertible debt, Ch. 33, 6.4.1.A

  securities, Ch. 37, 4.3.17

  convertible preference shares, Ch. 33, 6.4.1.B

  litigation settlements, Ch. 37, 4.3.6

  participating equity instruments, Ch. 33, 6.4.1.C

  related party transactions, Ch. 37, 4.3.9

  definitions, Ch. 33, 1.1

  reversal of restructuring provisions, Ch. 37, 4.3.3

  disclosure, Ch. 33, 7.3

  seasonality/cyclicality of operations, Ch. 37, 4.3.14

  matters affecting the numerator, Ch. 33, 5

  transfers between different levels of fair value

  earnings, Ch. 33, 5.1

  hierarchy, Ch. 37, 4.3.10

  Index

  151

  fair value disclosures for financial instruments, Ch. 37, 4.5

  corporate assets, Ch. 20, 4.2

  going concern assumption, disclosure in relation to,

  disclosures required by IAS 36, Ch. 20, 14

  Ch. 37, 4.7

  annual impairment disclosures for goodwill and intangible

  other disclosures required by IAS 34, Ch. 37, 4.2

  assets with an indefinite useful life, Ch. 20, 14.3

  segment information, Ch. 37, 4.4

  for impairment losses or reversals, Ch. 20, 14.2.1

  significant events and transactions, Ch. 37, 4.1

  material impairments, Ch. 20, 14.2.2

  specified disclosures, location of, Ch. 37, 4.2.1

  dividing the entity into cash-generating units (CGUs), Ch. 20, 3

  effective dates and transitional rules, Ch. 37, 11

  active markets and identifying CGUs, Ch. 20, 3.2

  consequential amendments to IFRS 7 when first adopting

  CGUs and intangible assets, Ch. 20, 3.1

  IFRS 9, Ch. 37, 11.2

  fair value less costs of disposal, Ch. 20, 6

  first-time presentation of interim reports complying with

  estimating, Ch. 20, 6.1

  IAS 34, Ch. 37, 11.1

  Depreciated replacement costs or current replacement

  estimates, use of, Ch. 37, 10

  cost as FVLCD, Ch. 20, 6.1.2

  materiality, Ch. 37, 6

  FVLCD and the unit of account, Ch. 20, 6.1.1

  objective, Ch. 37, 2.1

  first-time adopters of IAS 36, Ch. 5, 7.12

  periods for which interim financial statements are required to

  goodwill and its allocation to CGUs, Ch. 20, 8.1

  be presented, Ch. 37, 5

  composition of goodwill, Ch. 20, 8.1.1

  change in financial year-end, Ch. 37, 5.3

  effect of IFRS 8 on impairment tests, Ch. 20, 8.1.4

  comparatives following a financial period longer than a

  aggregation of operating segments for disclosure

  year, Ch. 37, 5.4

  purposes, Ch. 20, 8.1.4.B

  length of interim reporting period, Ch. 37, 5.2

  changes to operating segments, Ch. 20, 8.1.4.A

  other comparative information, Ch. 37, 5.1

  goodwill initially unallocated to CGUs, Ch. 20, 8.1.5

  when the comparative period is shorter than the current

  identifying synergies and identifying CGUs/CGU groups

  period, Ch. 37, 5.5

  for allocating goodwill, Ch. 20, 8.1.2

  recognition and measurement, Ch. 37, 8

  measuring the goodwill allocated to CGUs/CGU groups,

  examples of, Ch. 37, 9

  Ch. 20, 8.1.3

  contingent lease payments, Ch. 37, 9.7.4

  group and separate financial statement issues, Ch. 20, 12

  contractual/anticipated purchase price changes,

  VIU: relevant cash flows and non-arm’s length prices
,

  Ch. 37, 9.4.2

  Ch. 20, 12.1

  cost of sales, Ch. 37, 9.4

  goodwill in individual (or subgroup) financial statements

  earnings per share, Ch. 37, 9.8

  and the interaction with the group financial

  employee benefits, Ch. 37, 9.3

  statements, Ch. 20, 12.2

  foreign currency translation, Ch. 37, 9.6

  group reorganisations and the carrying value of

  interim period manufacturing cost variances, Ch. 37,

  investments in subsidiaries, Ch. 20, 12.3

  9.4.3

  investments in subsidiaries, associates and joint ventures,

  inventories, Ch. 37, 9.4.1

  Ch. 20, 12.4

  levies charged by public authorities, Ch. 37, 9.7.5

  impairment of intangible assets with an indefinite useful life,

  periodic maintenance/overhaul, Ch. 37, 9.7.3

  Ch. 20, 10

  property, plant and equipment and intangible assets,

  impairment losses, recognising and reversing, Ch. 20, 11

  Ch. 37, 9.1

  impairment losses and CGUs, Ch. 20, 11.2

  provisions, contingencies and accruals for other costs,

  on individual assets, Ch. 20, 11.1

  Ch. 37, 9.7

  reversal of impairment losses

  reversal of impairment losses recognised in a previous

  recognised in a previous interim period, Ch. 37, 9.2

  interim period (IFRIC 10), Ch. 37, 9.2

  relating to goodwill prohibited, Ch. 20, 11.3

  taxation, Ch. 37, 9.5

  relating to assets other than goodwill, Ch. 20, 11.4

  same accounting policies as in annual financial statements,

  impairment of goodwill, Ch. 20, 8

  Ch. 37, 8.1

  disposal of operation within a CGU to which goodwill has

  measurement on a year-to-date basis, Ch. 37, 8.1.1

  been allocated, Ch. 20, 8.5

  new accounting pronouncements and other changes in

  changes in composition of CGUs, Ch. 20, 8.5.1

  accounting policies, Ch. 37, 8.1.2

  impairment of assets and goodwill recognised on

  voluntary changes in presentation, Ch. 37, 8.1.3

  acquisition, Ch. 20, 8.3

  seasonal businesses, Ch. 37, 8.2

  deferred tax assets and losses of acquired businesses,

  costs incurred unevenly during the year, Ch. 37, 8.2.2

  Ch. 20, 8.3.2

  revenues received seasonally, cyclically, or occasionally,

  testing goodwill ‘created’ by deferred tax for

  Ch. 37, 8.2.1

  impairment, Ch. 20, 8.3.1

  scope, Ch. 37, 2.2

  impairment testing when a CGU crosses more than one

  use of estimates, Ch. 37, 10

  operating segment, Ch. 20, 8.4

  IAS 36– Impairment of Assets, Ch. 20, 1–14. See also Goodwill;

  when to test CGUs with goodwill for impairment, Ch. 20,

  Impairment of assets; Value in use (VIU)

  8.2

  carrying amount of CGU assets, identifying, Ch. 20, 4

  carry forward of a previous impairment test

  consistency and the impairment test, Ch. 20, 4.1

  calculation, Ch. 20, 8.2.3

  152 Index

  IAS 36– Impairment of Assets—contd

  definitions, Ch. 27, 1.3

  impairment of goodwill —contd

  disclosure requirements, Ch. 27, 7

  when to test CGUs with goodwill for impairment —contd

  contingent assets, Ch. 27, 7.3

  reversal of impairment loss for goodwill prohibited,

  contingent liabilities, Ch. 27, 7.2

  Ch. 20, 8.2.4

  provisions, Ch. 27, 7.1

  sequence of impairment tests for goodwill and other

  reduced disclosure when information is seriously

  assets, Ch. 20, 3.2.2

  prejudicial, Ch. 27, 7.4

  timing of impairment tests, Ch. 20, 8.2.1

  first-time adopters, Ch. 5, 7.13

  impairment review, features of, Ch. 20, 1.2.1

  interpretations related to the application of IAS 37, Ch. 27,

  impairment testing requirements, Ch. 20, 2

  1.2

  indicators of impairment, Ch. 20, 2.1

  measurement, Ch. 27, 4

  (future) performance, Ch. 20, 2.1.2

  anticipating future events that may affect the estimate of

  individual assets/part of CGU?, Ch. 20, 2.1.3

  cash flows, Ch. 27, 4.4

  interest rates, Ch. 20, 2.1.4

  best estimate of provision, Ch. 27, 4.1

  market capitalisation, Ch. 20, 2.1.1

  changes and uses of provisions, Ch. 27, 4.9

  non-controlling interests, impact on goodwill impairment

  changes in contingent liabilities recognised in a business

  testing, Ch. 7.4.2, Ch. 20, 9

  combination, Ch. 27, 4.10

  recoverable amount, Ch. 20, 5

  dealing with risk and uncertainty in measuring a provision,

  impairment of assets held for sale, Ch. 20, 5.1

  Ch. 27, 4.2

  scope of IAS 36, Ch. 20, 1.3

  discounting the estimated cash flows to a present value,

  theory behind, Ch. 20, 1.1

  Ch. 27, 4.3

  value in use (VIU), determining, Ch. 20, 7

  adjusting for risk and using a government bond rate,

  appropriate discount rate and discounting the future cash

  Ch. 27, 4.3.2

  flows, Ch. 20, 7.2

  effect of changes in interest rates on the discount rate

  approximations and short cuts, Ch. 20, 7.2.4

  applied, Ch. 27, 4.3.6

  calculating VIU using post-tax cash flows, Ch. 20,

  own credit risk is not taken into account, Ch. 27, 4.3.3

  7.2.3

  pre-tax discount rate, Ch. 27, 4.3.4

  determining pre-tax rates taking account of tax losses,

  real vs. nominal rate, Ch. 27, 4.3.1

  Ch. 20, 7.2.6

  unwinding of the discount, Ch. 27, 4.3.5

  disclosing pre-tax discount rates when using a post-tax

  joint and several liability, Ch. 27, 4.7

  methodology, Ch. 20, 7.2.5

  provisions are not reduced for gains on disposal of related

  discount rates and the weighted average cost of capital,

  assets, Ch. 27, 4.8

  Ch. 20, 7.2.1

  provisions that will be settled in a currency other than the

  entity-specific WACCs and capital structure, Ch. 20,

  entity’s functional currency, Ch. 27, 4.5

  7.2.8

  reimbursements, insurance and other recoveries from third

  entity-specific WACCs and different project risks

  parties, Ch. 27, 4.6

  within the entity, Ch. 20, 7.2.7

  objective of IAS 37, Ch. 27, 2.1

  pre-tax discount rate, calculating, Ch. 20, 7.2.2

  recognition, Ch. 27, 3

  use of discount rates other than the WACC, Ch. 20,

  contingencies, Ch. 27, 3.2

  7.2.9

  contingent assets, Ch. 27, 3.2.2

  fair value and value in use, differences between, Ch. 20,

  obligations contingent on the successful recovery of,

  7.3

  Ch. 27, 3.2.2.A

  future pre-tax cash flows of the CGU under review,

  contingent liabilities, Ch. 27, 3.2.1

  estimating, Ch. 20, 7.1

  how probability determines whether to recognise or

  budgets and cash flows, Ch. 20, 7.1.1

  disclose, Ch. 27, 3.2.3

  cash inflows and outflows from improvements and

  determining when a provision sh
ould be recognised,

  enhancements, Ch. 20, 7.1.2

  Ch. 27, 3.1

  events after the reporting period, Ch. 20, 7.1.8

  an entity has a present obligation as a result of a past

  foreign currency cash flows, Ch. 20, 7.1.5

  event, Ch. 27, 3.1.1

  internal transfer pricing, Ch. 20, 7.1.6

  it is probable that an outflow of resources embodying

  overheads and share-based payments, Ch. 20, 7.1.7

  economic benefits will be required to settle the

  restructuring, Ch. 20, 7.1.3

  obligation, Ch. 27, 3.1.2

  terminal values, Ch. 20, 7.1.4

  a reliable estimate can be made of the amount of the

  IAS 37– Provisions, Contingent Liabilities and Contingent Assets,

  obligation, Ch. 27, 3.1.3

  Ch. 27, 1–7. See also Provisions, contingent liabilities and

  recognising an asset when recognising a provision, Ch. 27,

  contingent assets

  3.3

  cases in which no provision should be recognised, Ch. 27, 5

  scope of IAS 37, Ch. 27, 2.2

  future operating losses, Ch. 27, 5.1

  distinction between provisions and contingent liabilities,

  rate-regulated activities, Ch. 27, 5.4

  Ch. 27, 2.2.3

  repairs and maintenance of owned assets, Ch. 27, 5.2

  items outside the scope of IAS 37, Ch. 27, 2.2.1

  staff training costs, Ch. 27, 5.3

  entities adopting IFRS 16, Ch. 27, 2.2.1.C

  Index

  153

  executory contracts, except where the contract is

  measuring the fair value of intangible assets, Ch. 17, 5.3

  onerous, Ch. 27, 2.2.1.A

  recognition of intangible assets acquired in a business

  items covered by another standard, Ch. 27, 2.2.1.B

  combination, Ch. 17, 5.1

  provisions compared to other liabilities, Ch. 27, 2.2.2

  amortisation of intangible assets, Ch. 17, 9

  specific examples of provisions and contingencies, Ch. 27, 6

  assessing the useful life of an intangible asset as

  decommissioning provisions, Ch. 27, 6.3

  finite/indefinite, Ch. 17, 9.1

  changes in estimated decommissioning costs (IFRIC

  factors affecting the useful life, Ch. 17, 9.1.1

  1), Ch. 27, 6.3.1

  useful life of contractual/other legal rights, Ch. 17, 9.1.2

  changes in legislation after construction of the asset,

  impairment losses, Ch. 17, 9.4

  Ch. 27, 6.3.2

  intangible assets with a finite useful life, Ch. 17, 9.2

  funds established to meet an obligation (IFRIC 5),

  amortisation period and method, Ch. 17, 9.2.1

  Ch. 27, 6.3.3

  amortisation of programme and other broadcast

  interaction of leases with asset retirement obligations,

  rights, Ch. 17, 9.2.1.B

 

‹ Prev